Skip to Content

VanEck Biotech ETF BBH

Medalist Rating as of | See VanEck Investment Hub

Morningstar’s Analysis BBH

Will BBH outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

VanEck Biotech ETF's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBH

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 74.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Amgen Inc

17.36 79.5 Mil
Healthcare

Vertex Pharmaceuticals Inc

11.21 51.3 Mil
Healthcare

Gilead Sciences Inc

9.38 42.9 Mil
Healthcare

Regeneron Pharmaceuticals Inc

9.16 42.0 Mil
Healthcare

IQVIA Holdings Inc

5.59 25.6 Mil
Healthcare

Moderna Inc

5.41 24.8 Mil
Healthcare

Icon PLC

4.87 22.3 Mil
Healthcare

Biogen Inc

4.17 19.1 Mil
Healthcare

argenx SE ADR

3.95 18.1 Mil
Healthcare

Illumina Inc

3.57 16.4 Mil
Healthcare